| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.5B | $6.3B | $5.9B | $5.5B | $4.7B | $4.1B | $4.2B | $4.0B |
| Cost of Revenue | $2.1B | $2.0B | $1.9B | $1.7B | $1.4B | $1.3B | $1.6B | $1.5B |
| Gross Profit | $4.5B | $4.3B | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.1B | $2.9B | $2.7B | $2.5B | $2.2B | $2.0B | $2.1B | $1.9B |
| Operating Income | $1.0B | $1.2B | $1.2B | $1.1B | $0.9B | $0.5B | $0.4B | $0.3B |
| Net Income | $0.7B | $1.3B | $0.9B | $0.8B | $0.8B | $0.3B | $0.2B | $0.1B |
| EPS (Basic) | $9.68 | $16.12 | $11.17 | $10.08 | $9.33 | $2.99 | $2.60 | $1.35 |
| EPS (Diluted) | $9.65 | $16.00 | $11.08 | $9.96 | $9.21 | $2.96 | $2.56 | $1.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1B | $8.5B | $7.8B | $7.3B | $7.4B | $7.3B | $7.2B | $6.2B |
| Current Assets | $4.1B | $4.2B | $3.4B | $2.8B | $2.6B | $2.3B | $2.0B | $1.8B |
| Cash & Equivalents | $1.7B | $1.9B | $1.3B | $0.7B | $0.8B | $0.7B | $0.3B | $0.2B |
| Total Liabilities | $7.8B | $7.2B | $7.2B | $7.1B | $7.0B | $6.2B | $6.2B | $5.4B |
| Current Liabilities | $4.1B | $4.0B | $3.8B | $3.6B | $3.4B | $2.9B | $2.9B | $2.6B |
| Stockholders' Equity | $0.3B | $1.4B | $0.7B | $0.2B | $0.4B | $1.1B | $0.9B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.5B | $1.2B | $1.1B | $1.3B | $0.9B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.1B | $-0.1B | $0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.4B | $-0.7B | $-0.6B | $-1.0B | $-1.2B | $-0.4B | $-0.3B | $-1.3B |